阜阳哪里医院治疗灰指甲比较好(阜阳哪里去治疗皮肤过敏好) (今日更新中)

HONG KONG, July 19 (Xinhua) -- A gene controlled by male hormone was critical for the growth of liver tumor, leading to a higher incidence of the disease in men than in women, according to the Chinese University of Hong Kong which made the results public on Tuesday.There is a significant gender bias in liver cancer incidence. In Hong Kong, men are three times more likely to develop liver cancer than women. Such phenomenon prompted researchers from the university to carry out a genomic location analysis in liver cancer cells starting from 2008.The researchers discovered, out of 17,000 human genes, that a gene called Cell Cycle-Related Kinase (CCRK) was directly controlled by androgen receptor. They further found that CCRK was critical for the induction of signaling pathway leading to abnormal liver cell growth and tumor formation.The results also reveal that 70 percent of patients with liver cancer were found to produce high levels of CCRK. More importantly, these patients were more likely to have late-stage cancers and lived shorter than those with low CCRK level.Using mouse models, the researchers found that either lowering the level or blocking the signaling pathway of CCRK in liver cancer cells could significantly reduce the tumor growth rate.The study has validated that CCRK is an important gene that has potential to cause liver cancer and the gene can be tested as a new targeted therapy in future.Vice-Chancellor of the university Joseph Sung, who is also team leader of the research project, said the results explained why men have a higher risk of liver cancer than women and helped push ahead with the development of a novel treatment of the disease.The above study results were published online in July in Journal of Clinical Investigation.

SEOUL, Sept. 26 (Xinhua) -- Samsung Electronics, the world's second-largest manufacturer of mobile phones, launched its first smartphones based on fourth-generation (4G) communication technology in a bid to meet growing demand for high-speed wireless services. Galaxy S2 LTE and Galaxy S2 HD LTE compatible with long- term evolution (LTE) technology were rolled out at a media event held in central Seoul on Monday. The two new smartphones support LTE with data transmission five times faster than the existing third-generation (3G) mobile phones, featuring functions offered by Galaxy S2 smartphones, the company said.The Galaxy S2 LTE is equipped with an Android 2.3, or the latest version of the Android platform, a 4.5-inch wide Super AMOLED display and a 1.5 gigahertz dual core processor, while the Galaxy S2 HD LTE is featuring a 4.65-inch high-definition (HD) AMOLED display with 110 percent natural color reproduction and 180- degree viewing angle. "The 4G LTE technology became the base for enjoying high-speed and high-resolution wireless services. The new products will meet rising demand for such services in an environment where global wireless operators are transitioning to 4G networks," Shin Jong-kyun, president and head of Samsung's mobile communications business, told reporters.Shin forecast sales of the new LTE smartphones would approach the ones of the existing Galaxy S series, adding that it may take time to reach the goal as the LTE networks have yet to be covered nationwide.Global sales of the Galaxy S2 smartphones reached more than 10 million units since its debut in April, according Samsung. The nation's top wireless carrier SK Telecom plans to offer LTE service nationwide by 2013, with the country's No. 3 mobile operator LG Uplus aiming to cover the service across the country next year.

STOCKHOLM, July 7 (Xinhua) -- A patient has been given a new trachea made from a synthetic scaffold seeded with his own stem cells in a Stockholm's hospital, the Swedish medical university Karolinska Institutet said on Thursday.The operation was performed on June 9th at Karolinska University Hospital in Huddinge and the patient, a 36-year old man, has been well on the way to recovery and would be discharged from the hospital on Friday, the university said in a statement.The patient had been suffering from late stage tracheal cancer with the tumor had reached approximately 6cm in length and was extending to the main bronchus.Since no suitable donor windpipe was available, the transplantation of the synthetic tissue engineered trachea was performed as the last possible option for the patient.The successful transplantation of tissue engineered synthetic organs, referred to as regenerative medicine, could open promising therapeutic possibilities for the thousands of patients who suffer from similar conditions.Transplantations of tissue engineered windpipes with synthetic scaffolds in combination with the patient's own stem cells as a standard procedure means that patients would not have to wait for a suitable donor organ.This would be a substantial benefit for patients since they could benefit from earlier surgery and have a greater chance of cure, according to the statement.

CANBERRA, Sept. 6 (Xinhua) -- A rare virus that can be contracted by humans has killed a large number of Victorian pigeons after being detected in the Australian state for the first time, Agriculture Department confirmed on Tuesday.According to the Australian Chief Veterinary Officer, Dr Mark Schipp, the avian paramyxo virus has already started killing some hobby birds, and threatens to spread to Victoria's chicken population.He said the affected birds have died suddenly in large numbers and have sometimes appeared tired or have shown neurological signs such as circling or head flicking before death.He added that the bug can also cause conjunctivitis or influenza-like symptoms in humans."The virus causes only mild, short-term conjunctivitis or influenza-like symptoms (in humans)," Australia Associated Press quoted Schipp as reporting on Tuesday."Human infection with this virus is extremely rare and usually occurs only in people who have close direct contact with infected birds."At this stage, there are no reports of the virus causing disease in wild birds, but the Australian Wildlife Health Network has been asked to monitor the situation.

BEIJING, Sept. 26 (Xinhuanet) -- Although it is home to traditional Chinese medicine (TCM), China must do much more to improve its academic research capacity for acupuncture, a form of TCM, to take the lead worldwide on both the academic and clinical sides.At present, among all academic theses on acupuncture indexed by the Science Citation Index (SCI), a leading world thesis index system, only 5 percent are from the Chinese mainland, according to Wang Linpeng, the director of the acupuncture and moxibustion center of the Beijing Hospital of Traditional Chinese Medicine, which is affiliated with the Capital Medical University.Although Chinese acupuncturists absolutely excel worldwide in clinical practice, "they are not as good as their foreign peers in academic capacity, particularly Western-style research methods and lab experiment design," he told China Daily on Friday during the 2011 International Symposium on Acupuncture. A patient suffering from facial paralysis receives acupuncture treatment at a hospital in Nanjing, the capital of Jiangsu province, on Dec 6, 2010.Studies by TCM practitioners - including acupuncturists - largely focus on their area of specialization, and few are in line with global interest in the medical science that has been proven effective over thousands of years, he said."Chinese TCM practitioners are very good at treating conditions, but they are clumsy at showing how and why it really works in an internationally accepted 'language' and 'manner'," said Gao Sihua, chancellor of the Beijing University of Chinese Medicine."It's especially true in TCM circles, where few Chinese practitioners would regularly follow international academic articles and research trends," Wang said.Measured by the number of articles on acupuncture indexed by SCI, the US and European countries lead globally, he said.

来源：资阳报